A detailed history of Baird Financial Group, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 32,250 shares of BLUE stock, worth $247,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,250
Previous 62,250 48.19%
Holding current value
$247,035
Previous $61,000 73.77%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.47 - $1.35 $14,100 - $40,500
-30,000 Reduced 48.19%
32,250 $16,000
Q2 2024

Aug 13, 2024

BUY
$0.85 - $1.26 $42,283 - $62,678
49,745 Added 397.8%
62,250 $61,000
Q1 2024

May 14, 2024

BUY
$0.91 - $1.75 $11,379 - $21,883
12,505 New
12,505 $16,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $591M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.